These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20380229)

  • 1. [Discharge letter with therapeutic recommendations: you have to sort out!].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Mar; 152(10):31-2. PubMed ID: 20380229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug treatment of insulin resistance].
    Tenoutasse S
    Rev Med Brux; 2009; 30(2):126-8. PubMed ID: 19517913
    [No Abstract]   [Full Text] [Related]  

  • 4. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of efficacy of combined therapy with antihypertensive agents and biguanides in patients with metabolic syndrome].
    Makolkin VI; Podzolkov VI; Napalkov DA
    Kardiologiia; 2004; 44(10):39-42. PubMed ID: 15477788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
    Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
    Nieuwdorp M; Stroes ES; Kastelein JJ;
    Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH
    Can Fam Physician; 1993 Jan; 39():119-20, 123-6. PubMed ID: 8435549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of complex therapy with metformin and ramipril combination for patients with metabolic syndrome].
    Kaĭdashev IP; Savchenko LH; Kaĭdasheva EI; Kutsenko NL; Kutsenko LO; Solokhina IL; Mamontova TV
    Lik Sprava; 2010; (7-8):77-84. PubMed ID: 21714292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing the tide of metabolic syndrome.
    Dumas MA
    Nurs Manage; 2003 Jun; 34 Suppl Guide():1-5. PubMed ID: 12867772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classic drug in diabetes therapy. Revise contraindications?].
    Aumiller J
    MMW Fortschr Med; 2007 May; 149(22):14. PubMed ID: 18074455
    [No Abstract]   [Full Text] [Related]  

  • 17. Case 2. Recurrence of myocardial infarction.
    Tanser P; Archer S; Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
    Naruszewicz M
    Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metformin should not be used by patients with reduced renal function].
    Gudmundsdottir H; Brørs O; Os I
    Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.
    Pala L; Mannucci E; Dicembrini I; Rotella CM
    Diabetes Res Clin Pract; 2007 Oct; 78(1):132-5. PubMed ID: 17445933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.